Adapalene in the treatment of melasma: A preliminary report [1]

Journal of Dermatology

Volumn 29, Issue 8, 2002, Pages 539-540

  Dogra, Sunil ^a   Kanwar, Amrinder J ^a   Parsad, Devinder ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Adapalene; Melasma; Tretinoin

Indexed keywords

ADAPALENE; RETINOIC ACID;

ADULT; CHLOASMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRY SKIN; FACE; FEMALE; HUMAN; LETTER; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; SUN EXPOSURE;

EID: 0036692524     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2002.tb00324.x     Document Type: Letter

References (7)

1. Usefulness of retinoic acid in the treatment of melasma
2. Topical tretinoin (retinoic acid) improves melasma. A vehicle controlled clinical trial
3. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial
4. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines
5. Pharmacodynamics and pharmacokinetics of topical adapalene
6. Comparative irritancy study among retinoid creams and gels
7. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: A meta-analysis of five randomized trials